• World Pharma Pricing and Market Access

    Tuesday 19 & Wednesday 20 March 2019  

    Beurs van Berlage  Amsterdam

    Market Access, Pricing, Value and Evidence

    Europe's Leading Pricing, Market Access and Evidence Congress for the Biopharma Industry
     

     

    FEATURED SPEAKER

    Thomas Mueller

    Head of Directorate General 1 "Drugs, Medical Devices, Biotechnology"

    Bundesministerium fur Gesundheit

  • World Pharma Pricing and Market Access

    19-20 March 2019  |  Amsterdam

     

    Market Access, Pricing, Value and Evidence

    Europe's Leading Pricing, Market Access and  Evidence  Congress for the Biopharma Industry

    FEATURED SPEAKER

     

    Carla Deakin

    Associate Director, Office for Market Access

    NICE

     

  • World Pharma Pricing and Market Access

    19-20 March 2019  |  Amsterdam

     

    Market Access, Pricing, Value and Evidence

    Europe's Leading Pricing, Market Access and  Evidence  Congress for the Biopharma Industry

    FEATURED SPEAKER

     

    Martina Flammer

    Senior Vice President, Head of Customer Value

    Boehringer Ingelheim Pharma GmbH & Co. KG

  • World Pharma Pricing and Market Access

    19-20 March 2019  |  Amsterdam

     

    Market Access, Pricing, Value and Evidence

    Europe's Leading Pricing, Market Access and  Evidence  Congress for the Biopharma Industry

    FEATURED SPEAKER

     

    Isabel Torres

    Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada

    Takeda

  •  

200 SPEAKERS

 

Thomas Mueller

Thomas Mueller

Head of Directorate General 1 "Drugs, Medical Devices, Biotechnology"

Bundesministerium fur Gesundheit

Carla Deakin

Carla Deakin

Associate Director, Office for Market Access

NICE

Omar Abbous

Omar Dabbous

Vice President Health Economics and Outcomes Research

AveXis Inc

Daria Tolkacheva, Head of Health Economics, BIOCAD

Daria Tolkacheva

Head of Health Economics 

BIOCAD

Oliver Gassner

Oliver Gassner

Head Digital Health Intelligence | EMEA

Bayer

Sue Naeyaert

Sue Naeyaert

Head Government Affairs and Policy Biosimilars

Fresenius Kabi

Andreia Ribeiro-Lifescience dynamics

Andreia Ribeiro

Engagement Manager

Lifescience Dynamics

Navin Joshi

Navin Joshi

Head of Pricing & Access Capabilities EMAP

GlaxoSmithKline

Elena Lungu

Elena Lungu

Manager NPDUIS (National Prescription Drug Utilisation Information System), Patented Medicine Prices Review Board 

Government Of Canada

Melvin Olson

Melvin Olson

Global Head RWD Strategy and Innovation

Novartis Pharma

Diane Munch, Head of Global Pricing, Patient & Health Impact, Pfizer

Diane Munch

Head of Global Pricing, Patient & Health Impact

Pfizer

Jane Erickson-Covance

Jane Erickson

Market Access & Phase IV Solutions

Covance

Oliver Leatham -Certara

Oliver Leatham

Global Head of Value & Access

Analytica-Laser - A Certara Company

Sune Lindgaard, Head of Section Business Intelligence and Health Economics, Amgros

Sune Lindgaard

Head of Section Business Intelligence and Health Economics 

Amgros

Diann Potestio, VP Market Access, Ascendis Pharma

Diann Potestio 

VP Market Access

Ascendis Pharma

Daniel Jackson

Daniel Jackson

Global Head of Market Access, Solutions and Strategy

UCB

Isabel Torres

Isabel Torres

Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada

Takeda

Marco Rauland

Marco Rauland

Vice President, MAP GM&E Training Academy, Global Market Access & Pricing Biopharma | Global Operations

Merck Group

Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN)

Ad Schuurman

Senior Advisor International Affairs 

National Health Care Institute (ZIN)

Martina Flammer

Martina Flammer

Senior Vice President, Head of Customer Value

Boehringer Ingelheim Pharma GmbH & Co. KG 

Luc Boileau, Président-directeur general, INESSS

Luc Boileau

Président-directeur general

INESSS

Sandy Leonard, Vice President of Medical Evidence and Observational Research, AstraZeneca

Sandy Leonard

Vice President of Medical Evidence and Observational Research

AstraZeneca

Patrick Hopkinson, Executive Director, WWHEOR Markets, Bristol Myers Squibb

Patrick Hopkinson

Executive Director, WWHEOR Markets

Bristol Myers Squibb

Margaret McDonald, Senior Director, Real World Data and Analytics, Global Health and Value, Pfizer

Margaret McDonald

Senior Director, Real World Data and Analytics, Global Health and Value

Pfizer

Neil Mulcock, Vice President Government Affairs and Policy, Gilead Sciences

Neil Mulcock

Vice President Government Affairs and Policy

Gilead Sciences

Reg Waldeck

Reg Waldeck

Market Access Strategy Leader

Bayer Corp

Ryan Saadi

Ryan Saadi 

 Global Vice President, Access, Pricing, HE&OR Global Commercial Development

CSL Behring

Diego Ardigò, R&D Rare Diseases Unit Head, Chiesi Group

Diego Ardigo

R&D Rare Diseases Unit Head

Chiesi Group

Wim Goettsch

Wim Goettsch

Special HTA-advisor 

Dutch National Health Care Institute (Zorginstituut Nederland)

Birgit Holz, Head of Contracting Innovation, Global Market Access, Sanofi

Birgit Holz

Head of Contracting Innovation, Global Access 

Sanofi

Keiko Tone, VP Global Market Access, Shionogi Inc

Keiko Tone

VP Global Market Access,

Shionogi Inc

Sheela Upadhyaya, Assoicate Director HST, National Institute for Health and Care Excellence

Sheela Upadhyaya

Associate Director HST

National Institute for Health and Care Excellence

Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma

Wills Hughes-Wilson 

Vice President, Head Of Patient Access And Commercial Planning

Mereo BioPharma

Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis

Jolanda Koenders

Head Of Pricing And Market Access Pharma 

Novartis

Chris Pashos, Vice President, Global Evidence Strategy, AbbVie

Chris Pashos

Vice President, Global Evidence Strategy

AbbVie

 

The what is the Pharma Pricing & Market Access Congress?

The World Pharma Pricing and Market Access Congress is Europe’s largest market access and pricing conference. Bringing together industry leaders from pharma companies, payers and HTAs, PPMA provides excellent opportunities to hear from patient led organisations, healthcare providers and other industry bodies. 

Join us in Amsterdam to discuss pricing, RWE, patient centricity and global market access all in one place. The 2019 edition will celebrate 11 years of success in providing attendees with practical valuable insight and the latest innovations taking place to help shape market access and evidence strategies.  

It’s about getting the right drug, to the right patient, at the right cost and achieving maximum reimbursement success.

  • "Excellent speakers and really good chance to network"

    Director Worldwide HEOR, BMS

    What attendees say about Pharma Pricing & Market Access
  • "Great networking; very useful to hear from a mix of pharma companies and payers about market access and evidence requirements”

    Head Global Pricing & Market Access, Vifor Pharma

    What attendees say about Pharma Pricing & Market Access
  • "Great speakers, perfect conference management"

    Head of Value Demonstration & Access & Public Affairs, Shire

    What attendees say about Pharma Pricing & Market Access
  • "Very good conference, useful blend of Market Access, Pricing and RWE. Helped to highlight the cross over”

    Research Business Development Associate, CK Aspire

    What attendees say about Pharma Pricing & Market Access
  • “Great opportunity to gain payer and industry insights in several 'hot' topics”

    Health Care Environment Manager EU Plus, Medac

    What attendees say about Pharma Pricing & Market Access

EARLY BIRD OFFER: SAVE €100

WHEN YOU REGISTER BY 1 March

early bird offer expires in

Days

Hours

Minutes

Seconds

 

REGISTER NOW

 

Who Attends

 

AMS

 

Topics to be Discussed in 2019

EVIDENCE

PRICING & MARKET ACCESS

RARE DISEASES

BIG DATA, DIGITAL HEALTH & ANALYTICS

HTA

EMERGING MARKETS

VALUE

REIMBURSEMENT

BIOSIMILARS

AFFORDABILITY

ADVANCED THERAPIES

ANALYTICS & DATA

MANAGED ENTRY AGREEMENTS

PATIENT AND PAYER ENGAGEMENT

CONTRACTING AND PRICE TENDERING

 

 

 

Present your product to the industry, contact us to find out more about exhibiting. 

Contact Edmond Rama at +44 (0)207 092 1052 or edmond.rama@terrapinn.com

 

 

Pharma pricing and market access congress

 

Sponsorship packages are tailored to meet your specific business development goals.

 

Download the prospectus to see how you can get involved.

 

DOWNLOAD PROSPECTUS

Sponsors & Exhibitors

 

TITLE SPONSOR

 

Covance

 

  • Platinum Sponsor

    Certara at Pharma Pricing & Market Access Congress 2019

    Platinum Sponsor

    Lifescience Dynamics Ltd at Pharma Pricing & Market Access Congress 2019
  • Gold Sponsor

    CRA,Charles River Associates at Pharma Pricing & Market Access Congress 2019

    Gold Sponsor

    Huron Consulting Group at Pharma Pricing & Market Access Congress 2019
  • Silver Sponsor

    https://decisionresourcesgroup.com/ at Pharma Pricing & Market Access Congress 2019

    Silver Sponsor

    Executive Insight AG at Pharma Pricing & Market Access Congress 2019
  • Silver Sponsor

    EVERSANA at Pharma Pricing & Market Access Congress 2019

    Silver Sponsor

    Evidera at Pharma Pricing & Market Access Congress 2019
  • Silver Sponsor

    inbeeo at Pharma Pricing & Market Access Congress 2019

    Silver Sponsor

    Navigant Consulting at Pharma Pricing & Market Access Congress 2019
  • Silver Sponsor

    Pharmerit International at Pharma Pricing & Market Access Congress 2019

    Silver Sponsor

    Precision Xtract at Pharma Pricing & Market Access Congress 2019
  • Silver Sponsor

    Syneos Health at Pharma Pricing & Market Access Congress 2019

    Silver Sponsor

    Vistex GmbH at Pharma Pricing & Market Access Congress 2019
  • Bronze Sponsor

    Axis Consulting at Pharma Pricing & Market Access Congress 2019

    Bronze Sponsor

    Methods Analytics at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Accession Healthcare Consulting at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    Access Infinity Ltd at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Barrington James at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    Cogvio at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Genesis Research Inc at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    Kleijnen Systematic Reviews Ltd at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Market Access Transformation at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    MKO Global Partners at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    NIHR Innovation Observatory, Newcastle University at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    Numerus Ltd at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    OPEN VIE at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    Pricing Executive Search at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Prioritis Market Access at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    R.J.W. and Partners Ltd at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Semalytix GmbH at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    SIRIUS Market Access at Pharma Pricing & Market Access Congress 2019
  • Exhibitor

    Valid Insight at Pharma Pricing & Market Access Congress 2019

    Exhibitor

    Wickenstones at Pharma Pricing & Market Access Congress 2019

 

SPONSORSHIP OPPORTUNITIES

STAY UPDATED

Sign Up for Event Updates

 

 

 

MARK YOUR CALENDARS NOW!

AMSTERDAM 19 - 20 MARCH 2019

 

 

Contact us

To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052

edmond.rama@terrapinn.com

To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com